PEAR   $0.03  -37.24% Market Open

Pear Therapeutics Inc
Last Events:

2023-03-30 Trend pattern changed from нисходящий треугольник to расширяющийся канал.

2023-03-30 Signal in Stochastic changed from bearish weakening to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-03-30 Signal in MACD changed from bearish recovery to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

2023-03-30 Trend Power changed from medium strength to strong.

2023-03-29 Trend pattern changed from расширяющийся канал to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bullish reversal to bearish weakening. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it crossed the signal line from the top and falls. These factors mean that the market confirms the tendency to fall. Last signal: main and signal line crossing.

2023-03-29 Trend Power changed from strong to medium strength.


Current temperature: 2.63
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 3
Target Price Mean 5.33
Mean unverified/preliminary 5.33 / 5.33
Target Price Low / High 2.00 / 9.00
Median / STD DEV 5.00 / 3.51
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Buy
rsi Sell Sell Buy
macd - Sell -
stoch Sell - -
ma20 - Sell -
ma50 Sell - -
ma100 Sell Sell -
Candlestick PatternApril 12, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US7047231052
ceo Dr. Corey M. McCann M.D., Ph.D.
Website https://peartherapeutics.com
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastroenterology, cardiology, and oncology. Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. On April 7, 2023, Pear Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.